BTS 25TH ANNIVERSARY
Tuberculosis
Tuberculosis and its future management
Correspondence to:
Dr John C Moore-Gillon, Department of Respiratory Medicine, St Bartholomews and Royal London Hospitals, London EC1A 7BE, UK; john.moore-gillon@bartsandthelondon.nhs.uk
Will we do better in the next 25 years?
| The first 150 words of the full text of this article appear below. |
Twenty-five years ago, most writers on tuberculosis (TB) would, if asked to predict what the position would be by 2007, have anticipated better diagnostics, safer drugs, shorter treatment times, a better vaccine, the near eradication of TB in the developed world and falling rates in the developing world. Some perceptive individuals were sounding the warning bells, but most pundits would have been profoundly wrong. They would have been closest to the mark if they had simply summed up their prediction of the position 25 years later, in 2007, as "Much the same, really—except where its much worse."
Predictions about TB are particularly fraught with difficulty because the impact of factors beyond the control of clinicians, researchers and the pharmaceutical industry is far greater with TB than it is in diseases like asthma, chronic obstructive pulmonary disease and lung cancer. These views on TB and its future management are therefore
This article has been cited by other articles:
-
Wedzicha, J. A, Johnston, S. L
(2008). Thorax update: October 2007-September 2008. Thorax
63: 1036-1037
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
